Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating expenses:    
Research and development $ 2,669,779 $ 2,436,998
General and administrative expenses 2,406,587 1,992,928
Total operating expenses 5,076,366 4,429,926
Loss from operations (5,076,366) (4,429,926)
Other income (expense):    
Sublease income 19,455  
Loss on debt conversion with related party   (6,134,120)
Interest income (expense), net 77,350 (147,090)
Exchange loss, net (5,860) (23,274)
Total other income (expense) 90,945 (6,304,484)
Loss before income taxes (4,985,421) (10,734,410)
Deferred income tax expense (1,193) (190,542)
Net loss (4,986,614) (10,924,952)
Accrual of paid-in-kind dividends on Series A Non-Voting Convertible Preferred Stock   (1,256,662)
Net loss attributable to common stockholders $ (4,986,614) $ (12,181,614)
Net loss per common share, basic (in dollars per share) $ (0.15) $ (8.45)
Net loss per common share, diluted (in dollars per share) $ (0.15) $ (8.45)
Weighted average number of shares outstanding - basic (in shares) 33,544,748 1,441,535
Weighted average number of shares outstanding - diluted (in shares) 33,544,748 1,441,535
Comprehensive loss    
Net loss $ (4,986,614) $ (10,924,952)
Foreign currency translation adjustment (1,133,911) 61,156
Comprehensive loss $ (6,120,525) $ (10,863,796)